[Dronedarone in High-risk Patients with Atrial Fibrillation : PALLAS Study]
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kober L, Torp-Pedersen C, McMurray J, Gotzsche O, Levy S, Crijns H
. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008; 358(25):2678-87.
DOI: 10.1056/NEJMoa0800456.
View
2.
Van Gelder I, Haegeli L, Brandes A, Heidbuchel H, Aliot E, Kautzner J
. Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace. 2011; 13(11):1517-25.
PMC: 3198586.
DOI: 10.1093/europace/eur192.
View
3.
Singh B, Connolly S, Crijns H, Roy D, Kowey P, Capucci A
. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med. 2007; 357(10):987-99.
DOI: 10.1056/NEJMoa054686.
View
4.
Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm A, Cappato R
. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J. 2009; 30(24):2969-77c.
DOI: 10.1093/eurheartj/ehp235.
View
5.
Hohnloser S, Crijns H, van Eickels M, Gaudin C, Page R, Torp-Pedersen C
. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009; 360(7):668-78.
DOI: 10.1056/NEJMoa0803778.
View